
Dare Bioscience fell 67.7% from $1.81 to $0.58, behind the S&P 500's +11.2%. Its worst day was Aug 14 (−32.1%), and its low came Nov 16 at $0.58.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Dare Bioscience shares rose 18.2%, while the S&P 500 fell 1.1%.
+18.2% · S&P 500 −1.1%
EPS of $-0.02 beat the $-0.35 estimate on $1.0M revenue (est. $1.0M).
+2.6% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
Dare Bioscience shares rose 52.0%, while the S&P 500 rose 0.2%.
+52.0%, the year's best day · S&P 500 +0.2%
Dare Bioscience closed at its highest level of the year, 80.7% above where the year started.
+5.1% · S&P 500 +0.8%
EPS of $-0.20 beat the $-0.31 estimate on $152,455.00 revenue (est. $601,600.00).
−24.1% · S&P 500 −1.2%
Dare Bioscience shares fell 31.6%, while the S&P 500 fell 0.2%.
−31.6% · S&P 500 −0.2%
EPS of $-0.20 beat the $-0.30 estimate on $187,546.00 revenue (est. $2,000.00).
−32.1%, the year's worst day · S&P 500 −0.2%
Where it ended: a close of $0.58 on Nov 16, 2026.
Nothing in the past 12 months.
All DARE dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DARE and SPY from Benzinga historical bars. Not investment advice.